Abstract:What's New? Cancer‐associated fibroblasts (CAFs) have distinct pro‐tumorigenic actions that affect the development and progression of pancreatic ductal adenocarcinoma (PDAC). Here, the authors replicated events of early pancreatic carcinogenesis in vitro and in vivo to better understand CAF migration in PDAC. CAF migration and myofibroblast differentiation in PDAC were found to be regulated by the ARP2/3 complex, which functions in actin cytoskeleton organization and lamellipodia formation. Experiments further indicate that ARP2/3 inhibition reduces CAF motility and TGFβ1‐mediated differentiation and uncovers a fibroblast migration‐related transcriptional signature linked to poor patient survival. The findings present ARP2/3 as a novel therapeutic target for PDAC treatment. The ARP2/3 complex, which orchestrates actin cytoskeleton organization and lamellipodia formation, has been implicated in the initiation of pancreatic ductal adenocarcinoma (PDAC). This study aims to clarify its impact on the activity of cancer‐associated fibroblasts (CAFs), key players in PDAC progression, and patient outcomes. Early pancreatic carcinogenesis was modeled in p48Cre; LSL‐KrasG12D mice with caerulein‐induced pancreatitis, complemented by in vitro studies on human immortalized pancreatic stellate cells (PSCs) and primary PDAC‐derived CAFs. Data were gained from microarray analysis, RNA sequencing (RNA‐seq), and single‐cell RNA sequencing (sc‐RNA‐seq), with subsequent bioinformatics analysis. We uncovered a specific transcriptional signature associated with fibroblast migration in early pancreatic carcinogenesis and linked it to poor survival in patients with PDAC. A pivotal role of the ARP2/3 complex in CAF migration was identified. Inhibition of the ARP2/3 complex markedly decreased CAF motility and induced significant morphological changes in vitro. Furthermore, its inhibition also hindered TGFβ1‐mediated myofibroblastic CAF differentiation but had no effect on IL‐1‐mediated inflammatory CAF differentiation. Our findings position the ARP2/3 complex as central to the migration and differentiation of myofibroblastic CAF. Targeting this complex presents a promising new therapeutic avenue for PDAC treatment.

Role and mechanism of actin-related protein 2/3 complex signaling in cancer invasion and metastasis: A review

How is the AKT/mTOR Pathway Involved in Cell Migration and Invasion?

Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho–Rho kinase axis and tumor microenvironment

The Arp2/3 complex mediates multigeneration dendritic protrusions for efficient 3-dimensional cancer cell migration

Expression Of The Arp2/3 Complex In Human Gliomas And Its Role In The Migration And Invasion Of Glioma Cells

Advances in Mechanisms of Cancer Cell Motility and Migration

ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma

Cortactin in cancer cell migration and invasion

LAMC2 Modulates the Acidity of Microenvironments to Promote Invasion and Migration of Pancreatic Cancer Cells Via Regulating AKT-dependent NHE1 Activity.

Spatiotemporal Regulation of Formin-Like 2 by Protein Kinase C in Invasive Motility

New Insights into the Regulation and Cellular Functions of the Arp2/3 Complex

Roles of Arf6 in cancer cell invasion, metastasis and proliferation

The role of microfibrillar‐associated protein 2 in cancer

Proteolytic and mechanical remodeling of the extracellular matrix by invadopodia in cancer

Arf proteins in cancer cell migration

Par3 promotes breast cancer invasion and migration through pull tension and protein nanoparticle-induced osmotic pressure

An ULK1/2-PXN mechanotransduction complex suppresses breast cancer cell migration

LncRNAs Regulate the Cytoskeleton and Related Rho/ROCK Signaling in Cancer Metastasis

Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development

WDR63 Inhibits Arp2/3‐dependent Actin Polymerization and Mediates the Function of P53 in Suppressing Metastasis

Role of Phosphatase of Regenerating Liver-3 in the Metastasis of Melanoma Cells